Analysis of data from The Cancer Genome Atlas (TCGA) revealed that compared to other common mitotic kinase genes, NEK2 is the most frequently amplified and/or overexpressed in breast cancer (Fig. 1A). This evidence concerns the gene NEK2 and breast carcinoma.